The patent EP4573198 was granted to Alnylam Pharmaceuticals on Jun 25, 2025. The application was originally filed on Aug 17, 2023 under application number EP23768982A. The patent is currently recorded with a legal status of "Request For Examination Was Made".

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents